Oruka Therapeutics Quote - ORKA

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

12.19

Bid

10.87

Ask

14.57

Volume

253,568

12.05 Day's Range 12.885

12.235 52 Week Range 31.13

Market Cap

426.632M

Previous Close

12.47

Open

12.47

Last Trade

12.79

Last Trade Time

Financial Volume

US$ 3,164,329

VWAP

12.4792

Average Volume (3m)

303,691

Shares Outstanding

34,998,550

Dividend Yield

PE Ratio

-80.26

Earnings Per Share (EPS)

-0.15

Revenue

Net Profit

-5.34M

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome ... ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.orukatx.com

Headquarters

Wilmington, Delaware, USA

Founded

Oruka Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker ORKA. The last closing price for Oruka Therapeutics was US$12.47. Over the last year, Oruka Therapeutics shares have traded in a share price range of US$ 12.235 to US$ 31.13.

Oruka Therapeutics currently has 34,998,550 shares outstanding. The market capitalization of Oruka Therapeutics is US$436.43 million. Oruka Therapeutics has a price to earnings ratio (PE ratio) of -80.26.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.51	-4.0157480315	12.7	13.62	12.235	432941	12.72837488	CS
4	-7.35	-37.6151484135	19.54	21.315	12.235	315821	15.38855642	CS
12	-15.5	-55.9768869628	27.69	28.69	12.235	303691	19.96735533	CS
26	-13.31	-52.1960784314	25.5	31.13	12.235	203776	21.19270992	CS
52	-13.31	-52.1960784314	25.5	31.13	12.235	203776	21.19270992	CS
156	-13.31	-52.1960784314	25.5	31.13	12.235	203776	21.19270992	CS
260	-13.31	-52.1960784314	25.5	31.13	12.235	203776	21.19270992	CS

ORKA - Frequently Asked Questions (FAQ)

What is the current Oruka Therapeutics share price?

The current share price of Oruka Therapeutics is US$ 12.19

How many Oruka Therapeutics shares are in issue?

Oruka Therapeutics has 34,998,550 shares in issue

What is the market cap of Oruka Therapeutics?

The market capitalisation of Oruka Therapeutics is USD 436.43M

What is the 1 year trading range for Oruka Therapeutics share price?

Oruka Therapeutics has traded in the range of US$ 12.235 to US$ 31.13 during the past year

What is the PE ratio of Oruka Therapeutics?

The price to earnings ratio of Oruka Therapeutics is -80.26

What is the reporting currency for Oruka Therapeutics?

Oruka Therapeutics reports financial results in USD

What is the latest annual profit for Oruka Therapeutics?

The latest annual profit of Oruka Therapeutics is USD -5.34M

What is the registered address of Oruka Therapeutics?

The registered address for Oruka Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Oruka Therapeutics website address?

The website address for Oruka Therapeutics is www.orukatx.com

Which industry sector does Oruka Therapeutics operate in?

Oruka Therapeutics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Symbol	Price	Vol.
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M

Symbol

Price

Vol.